These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 22525429)
1. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor simvastatin ameliorates renal fibrosis through HOXA13-USAG-1 pathway. Hamasaki Y; Doi K; Okamoto K; Ijichi H; Seki G; Maeda-Mamiya R; Fujita T; Noiri E Lab Invest; 2012 Aug; 92(8):1161-70. PubMed ID: 22525429 [TBL] [Abstract][Full Text] [Related]
2. Modulator of bone morphogenetic protein activity in the progression of kidney diseases. Yanagita M Kidney Int; 2006 Sep; 70(6):989-93. PubMed ID: 16871237 [TBL] [Abstract][Full Text] [Related]
3. Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome. Tanaka M; Asada M; Higashi AY; Nakamura J; Oguchi A; Tomita M; Yamada S; Asada N; Takase M; Okuda T; Kawachi H; Economides AN; Robertson E; Takahashi S; Sakurai T; Goldschmeding R; Muso E; Fukatsu A; Kita T; Yanagita M J Clin Invest; 2010 Mar; 120(3):768-77. PubMed ID: 20197625 [TBL] [Abstract][Full Text] [Related]
4. Artesunate attenuates unilateral ureteral obstruction-induced renal fibrosis by regulating the expressions of bone morphogenetic protein-7 and uterine sensitization-associated gene-1 in rats. Cao J; Wang W; Li Y; Xia J; Peng Y; Zhang Y; Xia A Int Urol Nephrol; 2016 Apr; 48(4):619-29. PubMed ID: 26865179 [TBL] [Abstract][Full Text] [Related]
5. Balance between bone morphogenetic proteins and their antagonists in kidney injury. Yanagita M Ther Apher Dial; 2007 Oct; 11 Suppl 1():S38-43. PubMed ID: 17976084 [TBL] [Abstract][Full Text] [Related]
6. Interactions between BMP-7 and USAG-1 (uterine sensitization-associated gene-1) regulate supernumerary organ formations. Kiso H; Takahashi K; Saito K; Togo Y; Tsukamoto H; Huang B; Sugai M; Shimizu A; Tabata Y; Economides AN; Slavkin HC; Bessho K PLoS One; 2014; 9(5):e96938. PubMed ID: 24816837 [TBL] [Abstract][Full Text] [Related]
7. Expression of BMP-7 and USAG-1 (a BMP antagonist) in kidney development and injury. Tanaka M; Endo S; Okuda T; Economides AN; Valenzuela DM; Murphy AJ; Robertson E; Sakurai T; Fukatsu A; Yancopoulos GD; Kita T; Yanagita M Kidney Int; 2008 Jan; 73(2):181-91. PubMed ID: 17943079 [TBL] [Abstract][Full Text] [Related]
8. Simvastatin attenuates silica-induced pulmonary inflammation and fibrosis in rats via the AMPK-NOX pathway. Bo C; Liu F; Zhang Z; Du Z; Xiu H; Zhang Z; Li M; Zhang C; Jia Q BMC Pulm Med; 2024 May; 24(1):224. PubMed ID: 38720270 [TBL] [Abstract][Full Text] [Related]
9. Simvastatin attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells. Yang T; Chen M; Sun T Cell Physiol Biochem; 2013; 31(6):863-74. PubMed ID: 23817018 [TBL] [Abstract][Full Text] [Related]
10. Febuxostat Prevents Renal Interstitial Fibrosis by the Activation of BMP-7 Signaling and Inhibition of USAG-1 Expression in Rats. Cao J; Li Y; Peng Y; Zhang Y; Li H; Li R; Xia A Am J Nephrol; 2015; 42(5):369-78. PubMed ID: 26680283 [TBL] [Abstract][Full Text] [Related]
11. Uterine Sensitization-Associated Gene-1 in the Progression of Kidney Diseases. Li X; Yue W; Feng G; Li J J Immunol Res; 2021; 2021():9752139. PubMed ID: 34414243 [TBL] [Abstract][Full Text] [Related]
12. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway. Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499 [TBL] [Abstract][Full Text] [Related]
13. Micheliolide ameliorates renal fibrosis by suppressing the Mtdh/BMP/MAPK pathway. Peng F; Li H; Li S; Wang Y; Liu W; Gong W; Yin B; Chen S; Zhang Y; Luo C; Zhou W; Chen Y; Li P; Huang Q; Xu Z; Long H Lab Invest; 2019 Jul; 99(8):1092-1106. PubMed ID: 30976056 [TBL] [Abstract][Full Text] [Related]
14. Simvastatin abates development of renal fibrosis in experimental renovascular disease. Chade AR; Zhu XY; Grande JP; Krier JD; Lerman A; Lerman LO J Hypertens; 2008 Aug; 26(8):1651-60. PubMed ID: 18622245 [TBL] [Abstract][Full Text] [Related]
15. USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney. Yanagita M; Oka M; Watabe T; Iguchi H; Niida A; Takahashi S; Akiyama T; Miyazono K; Yanagisawa M; Sakurai T Biochem Biophys Res Commun; 2004 Apr; 316(2):490-500. PubMed ID: 15020244 [TBL] [Abstract][Full Text] [Related]
16. Febuxostat inhibits TGF‑β1‑induced epithelial‑mesenchymal transition via downregulation of USAG‑1 expression in Madin‑Darby canine kidney cells in vitro. Lu L; Zhu J; Zhang Y; Wang Y; Zhang S; Xia A Mol Med Rep; 2019 Mar; 19(3):1694-1704. PubMed ID: 30628645 [TBL] [Abstract][Full Text] [Related]
17. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells. Sugiyama M; Kodama T; Konishi K; Abe K; Asami S; Oikawa S Biochem Biophys Res Commun; 2000 May; 271(3):688-92. PubMed ID: 10814523 [TBL] [Abstract][Full Text] [Related]
18. Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury. Yanagita M; Okuda T; Endo S; Tanaka M; Takahashi K; Sugiyama F; Kunita S; Takahashi S; Fukatsu A; Yanagisawa M; Kita T; Sakurai T J Clin Invest; 2006 Jan; 116(1):70-9. PubMed ID: 16341262 [TBL] [Abstract][Full Text] [Related]
19. Ursolic acid inhibits epithelial-mesenchymal transition in vitro and in vivo. Xu CG; Zhu XL; Wang W; Zhou XJ Pharm Biol; 2019 Dec; 57(1):169-175. PubMed ID: 30905239 [TBL] [Abstract][Full Text] [Related]